CQC revelations continue
June 21, 2013Sales and Marketing CQC, NHS, NICE
The turmoil at the Care Quality Commission (CQC) shows no sign of abating as MPs may summon the current leadership …
J&J opens office at Stevenage Bioscience Catalyst
June 21, 2013Manufacturing and Production, Research and Development J&J, JJ, bioscience, catalyst
Johnson & Johnson Innovation has establishment a partnering office at Stevenage Bioscience Catalyst to support emerging entrepreneurs and biotech firms …
Zaltrap ‘no’ from NICE
June 21, 2013Sales and Marketing NICE, Sanofi, Zaltrap
NICE is preparing to discard Sanofi’s Zaltrap as an NHS option for treating metastatic colorectal cancer (mCRC) that is resistant …
UK government keen to reduce drugs bill
June 21, 2013Sales and Marketing NHS, NICE, UK, VBP
The government has shown its hand in the drug pricing debate after asking for a 20% price cut on some …
John Garibotto joins Cellnovo’s Board
June 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cellnovo, Garibotto
UK-based medical device firm Cellnovo has appointed John Garibotto as a non-executive director. Garibotto is a 20-year veteran of the …
UK takes action to prevent API shortages
June 20, 2013Manufacturing and Production API, MHRA, shortages
The UK has unilaterally adopted a policy of allowing imports of active pharmaceutical ingredients (API) on the strength of pharmaceutical …
Sanofi makes Curie cancer deal
June 20, 2013Research and Development, Sales and Marketing Cancer, R&D, Sanofi, curie
Sanofi has signed a three-year research collaboration with the Curie Institute to identify new therapeutic targets which will help develop …
InHealthcare appoints NHS director
June 20, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing InHealthcare
Digital healthcare firm InHealthcare has appointed NHS director Simon Jones as its new commercial director.Jones has held positions in Acute Hospitals, Mental Health and …
Nine fined in EU pay-for-delay deals
June 20, 2013Manufacturing and Production, Sales and Marketing EU, Lundbeck, Merck, Ranbaxy
Nine pharma firms have been handed hefty fines by the European Commission over allegations that they willingly blocked generic versions …
CQC embroiled in ‘cover up’ row
June 20, 2013Sales and Marketing Mid Staffs, NHS. CQC, UHMB
The organisation responsible for inspecting health and care standards in the NHS is at the centre of a flaming political …
United Drug hires Abbott VP
June 19, 2013Manufacturing and Production, Research and Development, Sales and Marketing Abbott, United Drug
Healthcare services firm United Drug has appointed Brendan McAtamney as chief operating officer with effect from September. McAtamney will be …
GSK receives thrombosis offer
June 19, 2013Sales and Marketing GSK, aspen, thrombosis
GlaxoSmithKline has received an offer from South African firm Aspen Global Incorporated (AGI) to buy its injectable thrombosis treatments and …
Lilly pays Transition $7 million
June 19, 2013Research and Development, Sales and Marketing Transition, lilly
Eli Lilly is to take up its option to develop and commercialise a type 2 diabetes candidate, paying Canadian firm …
AstraZeneca chooses Cambridge for global HQ
June 19, 2013Research and Development, Sales and Marketing AstraZeneca, Cambridge, MedImmune
AstraZeneca has chosen the Cambridge Biomedical Campus on the outskirts of the city as a new research and corporate hub. …
Is Google Glass hospital ready?
June 19, 2013Medical Communications Google glass, langevin, venturebeat
Google Glass has the potential to greatly enhance medical practices in a number of ways. Among these is the ability to retrieve, …
DJM Digital Solutions appoints senior vice president
June 19, 2013Medical Communications, Sales and Marketing Creston, DJM
Digital healthcare agency DJM Digital Solutions has appointed Ray Manna as senior vice president, North America. Manna will report to …
Avastin gets GBM approval
June 18, 2013Research and Development, Sales and Marketing GBM, Roche, avastin
Roche has received a major boost with the first approval in early treatment of the most aggressive form of brain …
MedImmune signs diabetes deal
June 18, 2013Research and Development, Sales and Marketing AstraZeneca, MedImmune, diabetes
AstraZeneca R&D subsidiary MedImmune has signed a deal with privately-owned San Francisco-based NGM Biopharmaceuticals to discover novel therapeutics to treat …
J&J to pay up to $1 billion in Aragon deal
June 18, 2013Research and Development, Sales and Marketing Aragon, J&J, JJ, Zytiga
Johnson & Johnson could pay as much as $1 billion to buy prostate cancer specialist Aragon Pharmaceuticals. The acquisition includes …
Quality issues ‘leading cause of drug shortages’
June 18, 2013Manufacturing and Production ISPE, shortages
Shortages of key medicines have been increasing in recent years, and a new survey from the International Society for Pharmaceutical …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
